Insulet (NSDQ:PODD) today posted third quarter earnings that beat expectations on Wall Street and lifted its guidance for the remaining year.
The Billerica, Mass.-based company posted profits of $1.7 million, or 3¢ per share, on sales of $151.1 million for the three months ended September 30, seeing a 174.5% swing into the black while sales grew 24.1% compared with the same period during the previous year.
Read the whole story on our sister site, Drug Delivery Business News
The post Insulet Q3 beats The Street appeared first on MassDevice.
from MassDevice https://ift.tt/2zkxctI
Cap comentari:
Publica un comentari a l'entrada